Posted by Michael Wonder on 05 Nov 2020
Value assessment of antimicrobials and the implications for development, access, and funding of effective treatments: Australian stakeholder perspective
5 November 2020 - The frameworks used by health technology assessment agencies for value assessment of medicines aim to optimise health care resource allocation.
However, they may not be effective at capturing the value of antimicrobial drugs.
Read International Journal of Technology Assessment in Health Care article
